Mastering Your Ozempic Journey: What Is the Next Dose After 1 mg?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing follows a carefully structured titration schedule designed to minimize side effects while building therapeutic benefit. Once you reach the 1 mg weekly injection dose, the path forward depends on your individual tolerance, weight loss progress, and clinical response. Understanding what comes next helps you stay confident in your GLP-1 therapy journey.

Standard Semaglutide Dose Progression After 1 mg

The typical semaglutide titration protocol moves through four escalation steps: 0.25 mg, 0.5 mg, 1 mg, and then 1.7 mg or 2.4 mg during maintenance. Most patients spend 4 weeks at each dose level to allow their body to adapt and to assess appetite suppression and gastrointestinal tolerance. Clinical trials show that advancing to 1.7 mg or 2.4 mg produces additional weight loss benefits beyond what 1 mg alone delivers, with sustained efficacy over 12–24 months of continuous therapy.

Your healthcare provider determines the right next step based on several factors: whether you are experiencing adequate appetite suppression at 1 mg, your current weight loss trajectory, any side effects you may be managing, and your personal weight loss goals. Some patients reach their target weight at 1 mg and choose to maintain that dose indefinitely, while others benefit from advancing to a higher maintenance dose. PlexusDx providers work with you to evaluate these variables in real time and make individualized recommendations aligned with your treatment plan.

How 1.7 mg and 2.4 mg Semaglutide Doses Differ in Efficacy

Research comparing semaglutide maintenance doses reveals a dose-response relationship: patients using 2.4 mg weekly typically achieve 10–15% greater weight loss compared to those at 1 mg, with sustained metabolic benefits including improved insulin sensitivity and reduced cardiovascular risk markers. The 1.7 mg dose offers a middle ground, delivering meaningful additional weight loss while being better tolerated by some patients who experience appetite suppression or nausea at higher doses. Each dose level represents a thoughtful balance between efficacy and side effect burden.

The timing of advancement to 1.7 mg or 2.4 mg typically occurs 4–8 weeks after reaching stable tolerance at 1 mg. Your provider will monitor your progress using weight measurements, appetite symptoms, energy levels, and gastrointestinal comfort to decide whether escalation is warranted or whether maintaining 1 mg produces sufficient results for your health goals. Some patients plateau at 1 mg and never require higher doses; others find that moving up unlocks additional weight loss potential.

Managing Side Effects During Semaglutide Dose Increases

When advancing from 1 mg to 1.7 mg or 2.4 mg, mild nausea, constipation, or reduced appetite intensity may temporarily increase during the first 1–2 weeks at the new dose. These effects typically peak within days and subside within 2–4 weeks as your body adjusts to the higher drug exposure. Staying hydrated, eating protein-rich meals in smaller portions, and moving your body gently can significantly reduce discomfort during this transition period. PlexusDx providers counsel you on practical strategies to support this adjustment and remain engaged throughout your titration.

Serious side effects are rare with properly dosed semaglutide from licensed 503A compounding pharmacies, but persistent vomiting, severe abdominal pain, or signs of pancreatitis require immediate medical attention and a dose pause or reduction. Most patients find that the benefits of appetite control and steady weight loss far outweigh any temporary adjustment symptoms, especially when providers take a patient-centered approach to pacing your dose increases. Open communication with your PlexusDx team helps you navigate any concerns and stay confident in your therapy.

Personalizing Your Semaglutide Path with Genetic Insights

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

By mapping 14 weight-regulation pathways and 150+ genetic insights, PlexusDx helps your provider tailor your semaglutide escalation to match your individual biology rather than following a one-size-fits-all protocol. Patients using this genetic data report greater confidence in their dose progression, fewer unnecessary adjustments, and better long-term adherence to therapy. Your PlexusDx semaglutide subscription is $189 per month month-to-month, or from $149/mo on the 6-month plan—your dose may go up, but your price won't—making precision dosing accessible and affordable.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical dose progression from 1 mg semaglutide to the next level?

Most patients advance from 1 mg to 1.7 mg or 2.4 mg after 4–8 weeks of stable tolerance. Your PlexusDx provider evaluates your weight loss progress, appetite control, and side effect profile to determine if escalation is right for you. Some patients maintain excellent results at 1 mg indefinitely.

Does increasing semaglutide from 1 mg to 1.7 mg or 2.4 mg produce more weight loss?

Clinical trials demonstrate that 2.4 mg delivers 10–15% additional weight loss compared to 1 mg, with benefits sustained over 12–24 months. Individual responses vary, but advancing doses generally strengthens appetite suppression and metabolic improvements when tolerated well.

Does my price increase when my semaglutide dose goes up?

No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all dose levels—your dose may go up, but your price won't. This flat-rate pricing applies whether you're at 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg, and there are no insurance requirements or membership fees.

What side effects might I experience when moving from 1 mg to a higher semaglutide dose?

Temporary nausea, constipation, or reduced appetite intensity may occur during the first 1–2 weeks at a higher dose but typically resolve within 2–4 weeks. Staying hydrated, eating protein-rich foods, and gentle movement help minimize discomfort. Serious side effects are rare with properly compounded medication from licensed 503A pharmacies.

How can PlexusDx genetic testing help me decide whether to increase my semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Glp 1 Starting Dose
• Ozempic Starting Dose
• Maximus Glp 1
• Lifemd Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.